Lynwood Capital Management’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,800
Closed -$108K 177
2023
Q1
$108K Hold
9,800
0.1% 86
2022
Q4
$1K Hold
9,800
﹤0.01% 129
2022
Q3
$1K Hold
9,800
﹤0.01% 144
2022
Q2
$1K Sell
9,800
-3,540
-27% -$361 ﹤0.01% 143
2022
Q1
$3K Buy
+13,340
New +$3K ﹤0.01% 137